Han-Jong Kim Selected Research

Neoplasms (Cancer)

1/2013	Scoparone exerts anti-tumor activity against DU145 prostate cancer cells via inhibition of STAT3 activity.
10/2008	Activation of signal transducer and activator of transcription 3 through a phosphomimetic serine 727 promotes prostate tumorigenesis independent of tyrosine 705 phosphorylation.
3/2007	15-deoxy-Delta12,14-prostaglandin J2 inhibits transcriptional activity of estrogen receptor-alpha via covalent modification of DNA-binding domain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Han-Jong Kim Research Topics

Disease

3	Vascular Calcification 01/2016 - 02/2012
3	Atherosclerosis 11/2015 - 04/2009
3	Hyperplasia 01/2014 - 10/2009
3	Vascular System Injuries 01/2014 - 04/2009
3	Neoplasms (Cancer) 01/2013 - 03/2007
2	Mitochondrial Diseases (Mitochondrial Disease) 11/2015 - 02/2012
2	Fibrosis (Cirrhosis) 02/2012 - 01/2012
1	Wounds and Injuries (Trauma) 12/2018
1	Vascular Remodeling 01/2014
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2014
1	Neonatal Jaundice 01/2013
1	Prostatic Neoplasms (Prostate Cancer) 01/2013
1	Ureteral Obstruction 01/2012
1	Type 2 Diabetes Mellitus (MODY) 11/2010
1	Insulin Resistance 11/2010
1	Infections 11/2010
1	Thrombosis (Thrombus) 11/2010
1	Hepatocellular Carcinoma (Hepatoma) 02/2010
1	Nephrogenic Diabetes Insipidus 01/2009
1	Carcinogenesis 10/2008
1	Breast Neoplasms (Breast Cancer) 12/2006
1	Body Weight (Weight, Body) 07/2004
1	Familial Hypoadrenocorticism 05/2004
1	Dosage-sensitive sex reversal 05/2004

Drug/Important Bio-Agent (IBA)

2	pyruvate dehydrogenase kinase 4IBA 01/2016 - 11/2015
2	Phosphates (Orthophosphate)IBA 11/2015 - 02/2012
2	Dimethyl FumarateIBA 01/2014 - 01/2012
2	quinone (benzoquinone)IBA 01/2014 - 04/2009
2	Proteins (Proteins, Gene)FDA Link 01/2014 - 11/2010
2	Oxidoreductases (Dehydrogenase)IBA 01/2014 - 04/2009
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2013 - 10/2008
2	Thioctic Acid (Lipoic Acid)IBA 02/2012 - 11/2010
2	Collagen Type I (Type I Collagen)IBA 02/2012 - 01/2012
2	AntioxidantsIBA 02/2012 - 11/2010
2	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2012 - 01/2012
2	DNA (Deoxyribonucleic Acid)IBA 11/2010 - 12/2006
2	Messenger RNA (mRNA)IBA 11/2010 - 02/2010
2	Estrogen Receptor alphaIBA 03/2007 - 12/2006
1	CollagenIBA 12/2018
1	Interleukin-10 (Interleukin 10)IBA 12/2018
1	CytokinesIBA 12/2018
1	Interleukin-6 (Interleukin 6)IBA 12/2018
1	CalciumIBA 11/2015
1	Pyruvate Dehydrogenase Complex (Dehydrogenase Complex, Pyruvate)IBA 11/2015
1	NF-E2-Related Factor 2IBA 01/2014
1	scoparoneIBA 01/2013
1	AgarIBA 01/2013
1	Caspase 9IBA 02/2012
1	Adenosine Triphosphate (ATP)IBA 02/2012
1	Cytochromes c (Cytochrome c)IBA 02/2012
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2012
1	sulforaphaneIBA 02/2012
1	Fibronectins (Fibronectin)IBA 01/2012
1	Glucose (Dextrose)FDA LinkGeneric 11/2010
1	Selenoprotein PIBA 11/2010
1	p38 Mitogen-Activated Protein KinasesIBA 11/2010
1	RNA (Ribonucleic Acid)IBA 11/2010
1	ThapsigarginIBA 02/2010
1	ColforsinIBA 02/2010
1	TunicamycinIBA 02/2010
1	ClusterinIBA 10/2009
1	PyransIBA 04/2009
1	NAD (NADH)IBA 04/2009
1	beta-lapachoneIBA 04/2009
1	Antineoplastic Agents (Antineoplastics)IBA 04/2009
1	Vasopressins (Vasopressin)IBA 01/2009
1	Aquaporin 2IBA 01/2009
1	Serine (L-Serine)FDA Link 10/2008
1	Tyrosine (L-Tyrosine)FDA Link 10/2008
1	PPAR gammaIBA 03/2007
1	cyclopentenoneIBA 03/2007
1	LigandsIBA 12/2006
1	DisulfidesIBA 12/2006
1	5- ((4- (4- (diethylamino)butyl)- 1- piperidinyl)acetyl)- 10,11- dihydrobenzo(b,e)(1,4)diazepine- 11- oneIBA 12/2006
1	benzamideIBA 12/2006
1	Estrogen ReceptorsIBA 12/2006
1	Tamoxifen FDA LinkGeneric 12/2006
1	NucleotidesIBA 07/2004
1	Orphan Nuclear ReceptorsIBA 05/2004
1	Amino Acids FDA Link 05/2004

Therapy/Procedure

2	Therapeutics 04/2009 - 12/2006
1	Ligation 02/2012
1	Drug-Eluting Stents 11/2010
1	Stents 11/2010